Literature DB >> 24767144

CT and endoscopic evaluation of larynx and trachea in mucopolysaccharidoses.

Noriko Morimoto1, Masayuki Kitamura2, Motomichi Kosuga3, Torayuki Okuyama3.   

Abstract

BACKGROUND: Mucopolysaccharidoses (MPSs) are lysosomal storage disorders caused by lysosomal enzyme deficiencies that result in systemic accumulation of glycosaminoglycans (GAGs). Accumulation of GAGs in the upper airway can lead to respiratory failure. The aim of this study was to investigate changes of the airway by flexible endoscopy and CT.
METHODS: Thirty-five patients aging from 2 to 16 years (mean: 9.2±4.4 years) participated in this study. The majority had MPS I (n=5) or MPS II (n=25). The shape of the trachea and the cross-sectional trachea surface area (TSA) was determined at the Th1 and Th2 levels. Airway obstruction was evaluated from endoscopic findings and classified into 3 grades (Grades 0, 1, and 2). Forty-five patients in the control group who underwent tracheal CT for other conditions were retrospectively selected from the database.
RESULTS: Tracheal morphology was abnormal in 50-60%, which showed a transversely collapsing narrow trachea. Tracheal deformity was severe in MPS II and MPS IV. The mean TSA of the MPS patients was 55.5±29.0 mm(2) at Th1 and 61.4±29.0 mm(2) at Th2, while that of the control group was 90.1±41.9 mm(2) and 87.9±39.3 mm(2), respectively. Respiratory distress was noted in 15 of the 35 patients, among whom 7 patients showed tracheal deformity and 7 patients had laryngeal redundancy. Three patients had no abnormalities of the larynx or trachea, so other factors such as pharyngeal stenosis or lower airway stenosis might have contributed to their respiratory distress.
CONCLUSION: CT and flexible endoscopy allow quantitative and morphological evaluation of airway narrowing, which is beneficial for airway management in MPS children.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CT; Endoscopy; GAG deposit; Morphology; Tracheal cross-sectional surface area

Mesh:

Year:  2014        PMID: 24767144     DOI: 10.1016/j.ymgme.2014.03.013

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  10 in total

1.  Outcomes from 18 years of cervical spine surgery in MPS IVA: a single centre's experience.

Authors:  A Broomfield; K Zuberi; J Mercer; G Moss; N Finnegan; P Hensman; R Walker; S Bukhari; N B Wright; F Stewart; S A Jones; R Ramirez
Journal:  Childs Nerv Syst       Date:  2018-06-26       Impact factor: 1.475

2.  Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement.

Authors:  Rebecca Ahrens-Nicklas; Lars Schlotawa; Andrea Ballabio; Nicola Brunetti-Pierri; Mauricio De Castro; Thomas Dierks; Florian Eichler; Can Ficicioglu; Alan Finglas; Jutta Gaertner; Brian Kirmse; Joerg Klepper; Marcus Lee; Amber Olsen; Giancarlo Parenti; Arastoo Vossough; Adeline Vanderver; Laura A Adang
Journal:  Mol Genet Metab       Date:  2018-01-31       Impact factor: 4.797

Review 3.  ENT and mucopolysaccharidoses.

Authors:  Pier Marco Bianchi; Renato Gaini; Silvano Vitale
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 4.  The role of imaging in the skeletal involvement of mucopolysaccharidoses.

Authors:  Vincenzo Spina; Domenico Barbuti; Alberto Gaeta; Stefano Palmucci; Ernesto Soscia; Marco Grimaldi; Antonio Leone; Renzo Manara; Gabriele Polonara
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

5.  Laryngeal, Tracheal, and Bronchial Disease in the Mucopolysaccharidoses: Endoscopic Study.

Authors:  Paulo Pires de Mello; Anneliese Lopes Barth; Danielle de Araujo Torres; Mariana Pires de Mello Valente; Dafne Dain Gandelman Horovitz
Journal:  Diagnostics (Basel)       Date:  2020-01-10

Review 6.  Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations.

Authors:  Rossella Parini; Federica Deodato
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

7.  Anaesthetic Management in Mucopolysaccharidoses Patients: Clinical Experience in a Tertiary Hospital.

Authors:  Andreia Machado; Diana Rodrigues; Amélia Ferreira; José Dias; Patrícia Santos
Journal:  Cureus       Date:  2022-07-30

8.  Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis.

Authors:  M Rutten; P Ciet; R van den Biggelaar; E Oussoren; J G Langendonk; A T van der Ploeg; M Langeveld
Journal:  Orphanet J Rare Dis       Date:  2016-04-26       Impact factor: 4.123

Review 9.  Central airway pathology: clinic features, CT findings with pathologic and virtual endoscopy correlation.

Authors:  Daniel Barnes; José Gutiérrez Chacoff; Mariana Benegas; Rosario J Perea; Teresa M de Caralt; José Ramirez; Ivan Vollmer; Marcelo Sanchez
Journal:  Insights Imaging       Date:  2017-02-15

Review 10.  Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis.

Authors:  Karolina M Stepien; Andrew Bentley; Cliff Chen; M Wahab Dhemech; Edward Gee; Peter Orton; Catherine Pringle; Jonathan Rajan; Ankur Saxena; Govind Tol; Chaitanya Gadepalli
Journal:  Front Cardiovasc Med       Date:  2022-03-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.